CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taverna, D.
Right arrow Articles by Hynes, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taverna, D.
Right arrow Articles by Hynes, N. E.

Cell Growth & Differentiation, Vol 2, Issue 3 145-154, Copyright © 1991 by American Association of Cancer Research


ARTICLES

Epidermal growth factor receptor, platelet-derived growth factor receptor, and c-erbB-2 receptor activation all promote growth but have distinctive effects upon mouse mammary epithelial cell differentiation

D Taverna, B Groner and NE Hynes
Friedrich Miescher Institute, Basel, Switzerland.

Three different receptor tyrosine kinases, epidermal growth factor (EGF), c-erbB-2/neu, and platelet-derived growth factor (PDGF) receptors, have been found to be present in the mouse mammary epithelial cell line HC11. We have investigated the consequences of receptor activation on the growth and differentiation of HC11 cells. HC11 cells are normal epithelial cells which maintain differentiation-specific functions. Treatment of the cells with the lactogenic hormones glucocorticoids and prolactin leads to the expression of the milk protein beta-casein. Activation of EGF receptor has a positive effect on cell growth and causes the cells to become competent for the lactogenic hormone response. HC11 cells respond optimally to the lactogenic hormone mixture and synthesize high levels of beta-casein only if they have been kept previously in a medium containing EGF. Transfection of HC11 cells with the activated rat neuT receptor results in the acquisition of competence to respond to the lactogenic hormones even if the cells are grown in the absence of EGF. The activation of PDGF receptor, through PDGF-BB, also stimulates the growth of HC11 cells. Cells kept only in PDGF do not become competent for lactogenic hormone induction. The results show that activation of the structurally related EGF and c-erbB-2/neu receptors, but not the PDGF receptor, allows the HC11 cells to subsequently respond optimally to lactogenic hormones.


This article has been cited by other articles:


Home page
Biology OpenHome page
P. A. B. Klemmt, E. Resch, I. Smyrek, K. Engels, E. H. K. Stelzer, and A. Starzinski-Powitz
Alternative exon usage creates novel transcript variants of tumor suppressor SHREW-1 gene with differential tissue expression profile
Biology Open, November 15, 2016; 5(11): 1607 - 1619.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
Y. Zhang, F. Li, Y. Song, X. Sheng, F. Ren, K. Xiong, L. Chen, H. Zhang, D. Liu, C. J. Lengner, et al.
Numb and Numbl act to determine mammary myoepithelial cell fate, maintain epithelial identity, and support lactogenesis
FASEB J, October 1, 2016; 30(10): 3474 - 3488.
[Abstract] [Full Text] [PDF]


Home page
In VivoHome page
P. LISSONI, G. MESSINA, F. ROVELLI, F. BRIVIO, L. FUMAGALLI, S. VILLA, and E. BARTOLACELLI
HER2 Expression in Breast Cancer: Correlation with Endocrine Function and Psychological Status in Operable and Metastatic Breast Cancer
In Vivo, November 1, 2009; 23(6): 987 - 989.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Y. M. Sum, D. Segara, B. Duscio, M. L. Bath, A. S. Field, R. L. Sutherland, G. J. Lindeman, and J. E. Visvader
Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer
PNAS, May 24, 2005; 102(21): 7659 - 7664.
[Abstract] [Full Text] [PDF]


Home page
MCPHome page
S. Desrivieres, T. Prinz, N. Castro-Palomino Laria, M. Meyer, G. Boehm, U. Bauer, J. Schafer, T. Neumann, C. Shemanko, and B. Groner
Comparative Proteomic Analysis of Proliferating and Functionally Differentiated Mammary Epithelial Cells
Mol. Cell. Proteomics, October 1, 2003; 2(10): 1039 - 1054.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. J. Naylor, E. Ginsburg, T. P. Iismaa, B. K. Vonderhaar, D. Wynick, and C. J. Ormandy
The Neuropeptide Galanin Augments Lobuloalveolar Development
J. Biol. Chem., August 1, 2003; 278(31): 29145 - 29152.
[Abstract] [Full Text] [PDF]


Home page
EMBO Rep.Home page
G. Civenni, T. Holbro, and N. E. Hynes
Wnt1 and Wnt5a induce cyclin D1 expression through ErbB1 transactivation in HC11 mammary epithelial cells
EMBO Rep., February 1, 2003; 4(2): 166 - 171.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
C.-H. Heldin and B. Westermark
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
Physiol Rev, October 1, 1999; 79(4): 1283 - 1316.
[Abstract] [Full Text] [PDF]


Home page
EMBO J.Home page
D. Graus-Porta, R. R. Beerli, J. M. Daly, and N. E. Hynes
ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
EMBO J., April 1, 1997; 16(7): 1647 - 1655.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
S. Kannan, M. De Santis, M. Lohmeyer, D. J. Riese II, G. H. Smith, N. Hynes, M. Seno, R. Brandt, C. Bianco, G. Persico, et al.
Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells
J. Biol. Chem., February 7, 1997; 272(6): 3330 - 3335.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. Wartmann, N. Cella, P. Hofer, B. Groner, X. Liu, L. Hennighausen, and N. E. Hynes
Lactogenic Hormone Activation of Stat5 and Transcription of the {beta}-Casein Gene in Mammary Epithelial Cells Is Independent of p42 ERK2 Mitogen-activated Protein Kinase Activity
J. Biol. Chem., December 13, 1996; 271(50): 31863 - 31868.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
K. Yokote, B. Margolis, C.-H. Heldin, and L. Claesson-Welsh
Grb7 is a Downstream Signaling Component of Platelet-derived Growth Factor {alpha}- and {beta}-Receptors
J. Biol. Chem., November 29, 1996; 271(48): 30942 - 30949.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
G. Wirl, M. Hermann, P. Ekblom, and R. Fassler
Mammary epithelial cell differentiation in vitro is regulated by an interplay of EGF action and tenascin-C downregulation
J. Cell Sci., June 1, 1995; 108(6): 2445 - 2456.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
R. Chammas, D. Taverna, N. Cella, C. Santos, and N. E. Hynes
Laminin and tenascin assembly and expression regulate HC11 mouse mammary cell differentiation
J. Cell Sci., April 1, 1994; 107(4): 1031 - 1040.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1991 by the American Association of Cancer Research.